Feasibility Strategy for Independent Research Sites: How to Give Sponsors Better Answers, Faster

For many independent Research Sites, feasibility is one of the most important commercial moments in the entire Study pipeline. It is where a Sponsor or CRO moves from “This Site looks interesting” to “Can this Site actually execute this protocol?” That distinction matters.

A strong website can create visibility. A good capabilities deck can create interest. Business development can create relationships. But feasibility is where the Site has to support its claims with protocol-specific answers. That is why feasibility should not be treated as administrative paperwork. It is part of the Site’s business-development and Study-selection strategy.

What Is Clinical Trial Feasibility?

Feasibility is the process used to evaluate whether a Site can realistically conduct a particular Study. It usually involves questions about investigator experience, patient population, enrollment projections, competing Studies, Site resources, procedures, equipment, staffing, recruitment channels, and timelines. The Sponsor or CRO is trying to reduce uncertainty. They want to understand whether this Site can recruit and execute successfully.

Feasibility Is Different From a Capabilities Deck

Our guide to creating a Clinical Research Site capabilities deck focused on the document that communicates evergreen Site strengths. Feasibility asks whether those strengths can support this specific protocol.

For example, a capabilities deck might say “We have strong metabolic research experience.” Feasibility asks: how many adults ages 40–70 with Type 2 diabetes who meet this specific treatment history can this Site realistically screen in six months? The second question is much harder. It requires evidence and judgment.

Feasibility Should Begin Before the Questionnaire Arrives

Strong Sites do not wait until a CRO sends a 75-question form to begin thinking. They maintain current internal information such as investigator profiles, Study history, therapeutic experience, patient population, recruitment performance, staff capacity, equipment, and timelines. That reduces response time dramatically.

Build a Living Site Profile

Much feasibility information is reusable. Site information includes the legal entity, address, locations, and operating hours. Investigator information covers specialties, licenses, and research experience. Team information covers coordinators, regulatory staff, recruiters, and laboratory personnel. Infrastructure covers exam rooms, pharmacy, laboratory, storage, and equipment. Technology covers the CTMS, recruitment CRM, and participant communication tools. Keep this information updated. Do not rebuild it from scratch for every opportunity.

Separate Evergreen and Protocol-Specific Information

This is one of the most important feasibility principles. Evergreen information changes slowly: investigators, Site location, equipment, staffing, general patient access, and prior Study experience. Protocol-specific information changes for every Study: eligible population, enrollment estimate, competing Studies, visit burden, protocol procedures, and recruitment timeline.

A 2024 paper from an industry Site Feasibility Task Force — made up of representatives from Sponsors, CROs, and Sites — makes the same split, dividing Site feasibility into Profile, Capability, Performance, and Protocol-Specific phases so the information that rarely changes can be gathered early (Contemporary Clinical Trials Communications, 2024). Separating the two makes feasibility faster and more accurate.

Patient Population Estimates Need Discipline

One of the most difficult questions is “How many eligible participants can you enroll?” There is pressure to provide a strong number, and that creates risk. The Site should not answer based on optimism, total database size, or intuition alone. A useful estimate may consider the diagnosed population, age, treatment history, major criteria, geography, willingness to participate, and competing Studies.

The Task Force paper is candid about why this is hard: it notes that not all Sites have good data and tools for estimating enrollment activity, and that Sites are often basing estimates on only partial protocol information. Its recommendation is that Sites be as accurate as possible, using tools and data to estimate participant populations (Contemporary Clinical Trials Communications, 2024).

Start With the Available Population

Suppose the Site has 4,000 diabetes patients. That is not the enrollment pool. Now narrow it by diagnosis (the relevant subtype), age (the protocol range), treatment history (required medications or failures), geography (realistic travel), competing Studies (other enrollment opportunities), and expected interest (not everyone will participate). The final realistic pool may be a fraction of the original number. That is normal.

Avoid the “Database Size” Trap

A database of 50,000 people may look impressive. But the CRO needs to know how many are relevant to this protocol. A better feasibility response explains the source and relevance of the population. For example: “The Site maintains an active database of approximately X individuals, including a defined subset in the target therapeutic area, supplemented by investigator practice referrals and digital recruitment.” Use actual verified numbers when available.

Use Historical Study Data

Past performance is one of the strongest feasibility tools. Review prior Studies with a similar indication, age range, visit burden, geography, and treatment criteria. Look at leads, referrals, screenings, enrollments, screen failure, time to first participant, and enrollment velocity. Historical performance can make future forecasts more realistic — and our guide to measuring recruitment performance by Research Site covers how to capture that data.

Similar Protocols Matter More Than Unrelated Studies

A Site may have enrolled 80 participants in a vaccine Study. That does not necessarily predict rare neurological Study performance. Feasibility should prioritize the most comparable evidence. The question is not “Have we enrolled participants before?” It is “What prior experience best predicts this protocol?”

Consider Recruitment Sources

A feasibility response should explain how the Site expects to recruit. Possible channels include the investigator practice, the internal database, physician referrals, community outreach, digital advertising, bilingual recruitment, and centralized Sponsor recruitment. The stronger the Study-specific recruitment plan, the more credible the forecast becomes.

Recruitment Strategy Should Match the Population

For an Alzheimer’s Study, caregiver outreach may matter. For a pediatric Study, parents are the primary decision-makers. For a rare disease, specialist referral networks may be more important than broad Meta Ads. For a metabolic Study, large-scale digital recruitment may work well. Feasibility should demonstrate that the Site understands how this population will actually be reached.

Geography Should Be Included

Our earlier article on geographic targeting in clinical trial recruitment covered how far a campaign should reach. Feasibility should use the same thinking. Ask where eligible participants are, how far they will travel, how often the Study requires visits, and whether transportation barriers are expected. A Study with frequent visits may need a tighter recruitment area than one with limited Site attendance.

Competing Studies Can Change Everything

A Site may have an excellent patient population. But if it is already recruiting three Studies targeting the same participants, the opportunity is different. Sponsors need realistic answers about competition. Track active competing protocols, overlapping eligibility, enrollment timelines, and investigator commitments. Ignoring competition creates overly optimistic forecasts.

Investigator Availability Matters

The investigator may be qualified. But do they have enough time? Feasibility should consider existing Study load, clinic responsibilities, research availability, and backup investigators. Site-selection tools reflect this: a standardized Site Assessment Survey Instrument (SASI) published in 2024 expanded the usual site survey to include standardized assessments of site commitment time and team experience, among other factors that might better predict performance (Contemporary Clinical Trials, 2024).

Staff Capacity Matters Too

A Site may have 10 active Studies with 2 coordinators. Adding another complex protocol may create risk. Feasibility should account for coordinator workload, recruiter capacity, regulatory workload, and laboratory coverage. Winning a Study the Site cannot support is not growth.

Procedures Need Operational Review

Protocols may require ECG, infusions, specific laboratory processing, imaging, overnight stays, or specialized assessments. Do not answer “Yes” simply because the Site could theoretically outsource something. Confirm the equipment, staff, vendor relationships, timing, cost, and logistics.

Build a Protocol Review Checklist

Before submitting feasibility, review each of these:

Population: Do we have access?
Investigator: Is the PI appropriate and available?
Recruitment: Can we reach enough participants?
Staff: Do we have capacity?
Equipment: Can required procedures be performed?
Timelines: Can we meet startup expectations?
Competition: Are overlapping Studies active?
Operations: Can the Site execute reliably?

This creates more disciplined answers.

Give Realistic Enrollment Estimates

Suppose a Site believes it might enroll 15–20 participants. Do not automatically write 25 to appear competitive. Overcommitting may help during selection, but it can hurt later through missed enrollment, Sponsor frustration, and a poor performance history. A slightly conservative estimate that the Site exceeds can strengthen credibility.

Use Ranges When Appropriate

Sometimes a range is more honest. For example: “Based on the current population, major protocol criteria, and available recruitment channels, the Site estimates 2–4 enrollments per month after activation.” This communicates reasoning, and it may be stronger than one unsupported total.

Explain the Assumptions

A good forecast can include the expected recruitment sources, the estimated eligible population, the screening conversion, and the enrollment period. That makes the estimate more defensible.

Response Speed Matters

Feasibility opportunities often move quickly, so Sites should establish internal service levels. For example: Day 0, the request is received; Day 1, PI review; Day 2, population and recruitment review; Day 3, final feasibility submitted. The exact timing will vary. The principle is that feasibility should have an owner and a timeline.

Build a Feasibility Workflow

A useful workflow runs: Opportunity Received → BD Review → PI Interest Confirmed → Protocol Review → Population Assessment → Operational Assessment → Recruitment Forecast → Final Submission. This prevents questionnaires from sitting in email.

One Person Should Own the Process

Several teams may contribute, but one person should be accountable. The owner could be Business Development, the Site Director, or a Feasibility Manager. Without ownership, feasibility becomes fragmented.

Do Not Let the PI Complete Everything Alone

Investigators provide essential clinical judgment. But they may not know digital recruitment performance, coordinator capacity, the current database, competing Study details, or marketing geography. Feasibility is a cross-functional process.

Recruitment Teams Should Contribute

Marketing and recruitment can provide population estimates, historic campaign performance, geographic data, bilingual capability, and expected recruitment channels. This creates a stronger projection.

Operations Should Validate Capacity

Operations can confirm staffing, equipment, Site space, screening slots, and timelines. Feasibility needs both demand and execution.

Build a Feasibility Database

Track historical submissions. Useful fields include the Sponsor, CRO, therapeutic area, indication, proposed enrollment, outcome, whether the Study was awarded, and actual enrollment. Over time, this becomes valuable intelligence.

Compare Forecast to Actual Performance

This is one of the best ways to improve future feasibility. For each Study, compare projected enrollment with actual enrollment. If the Site repeatedly predicts 20 and enrolls 8, forecasting needs improvement. If it predicts 10 and regularly enrolls 12, the model may be strong.

Learn Your Bias

Some Sites systematically overestimate. Others underestimate. Tracking forecast accuracy allows correction. Feasibility becomes a learned capability.

Use Data to Improve Future Site Selection

Historical feasibility data can reveal the strongest therapeutic areas, the best geographies, the most productive investigators, and the protocol types that underperform. This should influence business development. The Site can stop chasing poor-fit opportunities.

Feasibility and Business Development Should Work Together

Business development wants more Study opportunities. Feasibility should ensure the right Study opportunities. The Site should not win every Study. It should win Studies it can perform well — and our article on business development for Clinical Research Sites covers how those opportunities are generated in the first place.

Saying “No” Can Be Strategic

Sometimes the best feasibility answer is to decline. Reasons might include an insufficient population, a PI conflict, staff capacity, protocol complexity, a competing Study, or an unrealistic timeline. A disciplined Site protects its reputation.

But Explain Why

A professional decline can preserve the relationship. For example: “We appreciate the opportunity. After reviewing the protocol requirements and current enrollment commitments, we do not believe we can provide a realistic recruitment forecast for this Study at this time.” That is better than accepting and failing.

Feasibility Is Part of the Site Brand

Every feasibility interaction communicates responsiveness, organization, transparency, and accuracy. A strong process reinforces Site positioning. A chaotic process undermines it. Our article on marketing a Research Site to Sponsors and CROs covers what decision-makers look for during this stage.

Make Supporting Information Easy to Access

Maintain the current capabilities deck, the Site profile, investigator CVs, the equipment list, licenses, and a recruitment overview. This allows rapid follow-up when requested.

Feasibility Should Connect to the CRM

Business-development CRM stages might run: Opportunity → Feasibility Received → Feasibility Submitted → Site Visit / Follow-Up → Selected → Awarded. This allows the Site to measure feasibility volume, conversion, and Study awards.

Measure Feasibility Conversion

Useful KPIs include feasibility invitations (how many?), submissions (how many completed?), Site selection rate (how many progressed?), award rate (how many Studies won?), and forecast accuracy (how close was projected enrollment to actual?). This turns feasibility into a measurable business process.

Track Lost Opportunities

When possible, identify why Studies were not awarded. Reasons may include population, geography, Sponsor preference, a competing Site, investigator experience, or startup timing. Not every loss is actionable, but patterns matter.

Keep Marketing Claims and Feasibility Aligned

If the website says “Exceptional bilingual recruitment” but feasibility reveals no Spanish-speaking staff, credibility suffers. Marketing should reflect real operations. Feasibility tests whether the positioning is true.

A Practical Feasibility Strategy

Strong independent Sites can follow this sequence:

Maintain evergreen Site data. Keep the basic profile current.
Review the protocol. Understand the real requirements.
Validate investigator fit. Expertise plus availability.
Estimate the population. Use real sources.
Evaluate recruitment. Define how participants will be reached.
Confirm capacity. Staff plus facilities.
Evaluate competition. Know the overlapping Studies.
Build a realistic forecast. Avoid optimism bias.
Respond quickly. Use defined ownership.
Track the outcome. Learn from the award and actual enrollment.

This creates a repeatable feasibility system.

Feasibility Should Reduce Risk for Both Sides

The Sponsor wants to avoid selecting a Site that cannot perform. The Site should avoid accepting a Study it cannot execute. Good feasibility protects both. That is why honest answers are strategically valuable.

Better Feasibility Creates Better Growth

A mature feasibility process helps the Site win better-fit Studies, produce stronger enrollment, build Sponsor trust, improve future forecasts, and create repeat opportunities. Business development creates opportunities. Feasibility filters them. Operations proves the decision.

Frequently Asked Questions

What is clinical trial Site feasibility?

It is the process used to evaluate whether a Research Site has the investigators, participant population, recruitment capability, infrastructure, staff, and operational capacity required to conduct a specific protocol.

How should Research Sites estimate enrollment?

Sites should consider protocol criteria, historical performance, patient population, geography, competing Studies, recruitment channels, Site capacity, and enrollment timeline.

Should Sites provide aggressive enrollment estimates to win Studies?

No. Unrealistic projections can damage performance and long-term Sponsor/CRO trust. Feasibility should be evidence-based.

What information should a Site maintain before feasibility requests arrive?

Useful evergreen information includes investigators, Site locations, staff, equipment, therapeutic experience, Study history, recruitment capability, and patient population.

How can Sites improve feasibility response time?

Maintain updated Site data, define one workflow owner, involve the PI, recruitment, and operations teams early, and use a standardized internal protocol-review checklist.